CD34 and coronary artery disorder: Furthermore, our phase I and II clinical trials previously demonstrated that intracoronary transfusion of CD34 + cells improved left ventricular function in patients with diffuse coronary artery disease (CAD) and noncandidates for coronary artery intervention [22, 23].